# Wheels Up Experience Inc.: financial statements, quarterly

UP · NYSE · CIK 1819516 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/up.md) · [Financials](/companies/up/financials.md) · [Filings](/companies/up/filings.md) · [Insiders](/companies/up/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/up/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [320](/filings/0001819516-24-000066.md) | [246 d](/filings/0001628280-26-016512.md) | [197](/filings/0001819516-25-000028.md) | [196](/filings/0001819516-25-000044.md) | [194](/filings/0001628280-25-049230.md) | [205 d](/filings/0001628280-26-016512.md) | [178](/filings/0001628280-26-033583.md) | [190](/filings/0001628280-26-053559.md) | [185](/filings/0001628280-25-049230.md) | [184 d](/filings/0001628280-26-016512.md) | [169](/filings/0001628280-26-033583.md) | [182](/filings/0001628280-26-053559.md) |
| Cost of revenue | $m | [300](/filings/0001819516-24-000066.md) | [251 d](/filings/0001628280-26-016512.md) | [198](/filings/0001819516-25-000028.md) | [192](/filings/0001819516-25-000044.md) | [167](/filings/0001628280-25-049230.md) | [176 d](/filings/0001628280-26-016512.md) | [158](/filings/0001628280-26-033583.md) | [174](/filings/0001628280-26-053559.md) | [173](/filings/0001628280-25-049230.md) | [157 d](/filings/0001628280-26-016512.md) | [159](/filings/0001628280-26-033583.md) | [160](/filings/0001628280-26-053559.md) |
| Research and development | $m | [20.0](/filings/0001819516-24-000066.md) | [11.6 d](/filings/0001628280-26-016512.md) | [11.1](/filings/0001819516-25-000028.md) | [10.5](/filings/0001819516-25-000044.md) | [9.6](/filings/0001628280-25-049230.md) | [9.5 d](/filings/0001628280-26-016512.md) | [10.5](/filings/0001628280-26-033583.md) | [9.4](/filings/0001628280-26-053559.md) | [10.2](/filings/0001628280-25-049230.md) | [8.7 d](/filings/0001628280-26-016512.md) | [8.7](/filings/0001628280-26-033583.md) | [8.8](/filings/0001628280-26-053559.md) |
| Operating income | $m | [(129)](/filings/0001819516-24-000066.md) | [(64.9) d](/filings/0001628280-26-016512.md) | [(84.5)](/filings/0001819516-25-000028.md) | [(79.1)](/filings/0001819516-25-000044.md) | [(41.9)](/filings/0001628280-25-049230.md) | [(53.3) d](/filings/0001628280-26-016512.md) | [(80.8)](/filings/0001628280-26-033583.md) | [(59.6)](/filings/0001628280-26-053559.md) | [(61.3)](/filings/0001628280-25-049230.md) | [(1.7) d](/filings/0001628280-26-016512.md) | [(57.4)](/filings/0001628280-26-033583.md) | [(74.4)](/filings/0001628280-26-053559.md) |
| Interest expense | $m | [11.3](/filings/0001819516-23-000059.md) | [14.2 d](/filings/0001819516-24-000015.md) | [14.6](/filings/0001819516-24-000027.md) | [16.7](/filings/0001819516-24-000047.md) | [16.0](/filings/0001628280-25-049230.md) | [18.1 d](/filings/0001628280-26-016512.md) | [19.9](/filings/0001628280-26-033583.md) | [22.1](/filings/0001628280-26-053559.md) | [23.5](/filings/0001628280-25-049230.md) | [25.0 d](/filings/0001628280-26-016512.md) | [25.3](/filings/0001628280-26-033583.md) | [33.0](/filings/0001628280-26-053559.md) |
| Income tax | $m | [0.6](/filings/0001819516-24-000066.md) | [0.6 d](/filings/0001628280-26-016512.md) | [(0.1)](/filings/0001819516-25-000028.md) | [0.4](/filings/0001819516-25-000044.md) | [0.4](/filings/0001628280-25-049230.md) | [0.5 d](/filings/0001628280-26-016512.md) | [0.1](/filings/0001628280-26-033583.md) | [1.0](/filings/0001628280-26-053559.md) | [1.3](/filings/0001628280-25-049230.md) | [1.1 d](/filings/0001628280-26-016512.md) | [0.5](/filings/0001628280-26-033583.md) | [(0.1)](/filings/0001628280-26-053559.md) |
| Net income | $m | [(145)](/filings/0001819516-24-000066.md) | [(81.1) d](/filings/0001628280-26-016512.md) | [(97.4)](/filings/0001819516-25-000028.md) | [(97.0)](/filings/0001819516-25-000044.md) | [(57.7)](/filings/0001628280-25-049230.md) | [(87.5) d](/filings/0001628280-26-016512.md) | [(99.3)](/filings/0001628280-26-033583.md) | [(82.3)](/filings/0001628280-26-053559.md) | [(83.7)](/filings/0001628280-25-049230.md) | [(28.9) d](/filings/0001628280-26-016512.md) | [(83.0)](/filings/0001628280-26-033583.md) | [(107)](/filings/0001628280-26-053559.md) |
| Diluted EPS | $ per share | [(3.51)](/filings/0001819516-24-000066.md) | not reported | [(0.14)](/filings/0001819516-25-000028.md) | [(0.14)](/filings/0001819516-25-000044.md) | [(0.08)](/filings/0001628280-25-049230.md) | not reported | [(2.84)](/filings/0001628280-26-033583.md) | [(2.35)](/filings/0001628280-26-053559.md) | [(0.12)](/filings/0001628280-25-049230.md) | not reported | [(2.29)](/filings/0001628280-26-033583.md) | [(2.97)](/filings/0001628280-26-053559.md) |
| Basic EPS | $ per share | [(3.51)](/filings/0001819516-24-000066.md) | not reported | [(0.14)](/filings/0001819516-25-000028.md) | [(0.14)](/filings/0001819516-25-000044.md) | [(0.08)](/filings/0001628280-25-049230.md) | not reported | [(2.84)](/filings/0001628280-26-033583.md) | [(2.35)](/filings/0001628280-26-053559.md) | [(0.12)](/filings/0001628280-25-049230.md) | not reported | [(2.29)](/filings/0001628280-26-033583.md) | [(2.97)](/filings/0001628280-26-053559.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [245](/filings/0001819516-23-000059.md) | [264](/filings/0001819516-25-000012.md) | [181](/filings/0001819516-24-000027.md) | [141](/filings/0001819516-24-000047.md) | [116](/filings/0001819516-24-000066.md) | [216](/filings/0001628280-26-016512.md) | [172](/filings/0001819516-25-000028.md) | [107](/filings/0001819516-25-000044.md) | [125](/filings/0001628280-25-049230.md) | [134](/filings/0001628280-26-053559.md) | [54.1](/filings/0001628280-26-033583.md) | [86.3](/filings/0001628280-26-053559.md) |
| Current assets | $m | [410](/filings/0001819516-23-000059.md) | [434](/filings/0001819516-25-000012.md) | [333](/filings/0001819516-24-000027.md) | [289](/filings/0001819516-24-000047.md) | [271](/filings/0001819516-24-000066.md) | [332](/filings/0001628280-26-016512.md) | [299](/filings/0001819516-25-000028.md) | [234](/filings/0001819516-25-000044.md) | [248](/filings/0001628280-25-049230.md) | [249](/filings/0001628280-26-053559.md) | [165](/filings/0001628280-26-033583.md) | [222](/filings/0001628280-26-053559.md) |
| Total assets | $m | [1,328](/filings/0001819516-23-000059.md) | [1,316](/filings/0001819516-25-000012.md) | [1,181](/filings/0001819516-24-000027.md) | [1,086](/filings/0001819516-24-000047.md) | [1,043](/filings/0001819516-24-000066.md) | [1,158](/filings/0001628280-26-016512.md) | [1,091](/filings/0001819516-25-000028.md) | [1,006](/filings/0001819516-25-000044.md) | [973](/filings/0001628280-25-049230.md) | [969](/filings/0001628280-26-053559.md) | [916](/filings/0001628280-26-033583.md) | [927](/filings/0001628280-26-053559.md) |
| Current liabilities | $m | [869](/filings/0001819516-23-000059.md) | [908](/filings/0001819516-25-000012.md) | [879](/filings/0001819516-24-000027.md) | [874](/filings/0001819516-24-000047.md) | [888](/filings/0001819516-24-000066.md) | [917](/filings/0001628280-26-016512.md) | [925](/filings/0001819516-25-000028.md) | [902](/filings/0001819516-25-000044.md) | [888](/filings/0001628280-25-049230.md) | [908](/filings/0001628280-26-053559.md) | [854](/filings/0001628280-26-033583.md) | [785](/filings/0001628280-26-053559.md) |
| Total liabilities | $m | [1,182](/filings/0001819516-23-000059.md) | [1,216](/filings/0001819516-25-000012.md) | [1,169](/filings/0001819516-24-000027.md) | [1,157](/filings/0001819516-24-000047.md) | [1,157](/filings/0001819516-24-000066.md) | [1,354](/filings/0001628280-26-016512.md) | [1,371](/filings/0001819516-25-000028.md) | [1,353](/filings/0001819516-25-000044.md) | [1,348](/filings/0001628280-25-049230.md) | [1,361](/filings/0001628280-26-053559.md) | [1,382](/filings/0001628280-26-033583.md) | [1,487](/filings/0001628280-26-053559.md) |
| Long-term debt | $m | [235](/filings/0001819516-23-000059.md) | [235](/filings/0001819516-25-000012.md) | [223](/filings/0001819516-24-000027.md) | [219](/filings/0001819516-24-000047.md) | [210](/filings/0001819516-24-000066.md) | [376](/filings/0001628280-26-016512.md) | [383](/filings/0001819516-25-000028.md) | [391](/filings/0001819516-25-000044.md) | [394](/filings/0001628280-25-049230.md) | [316](/filings/0001628280-26-053559.md) | [400](/filings/0001628280-26-033583.md) | [581](/filings/0001628280-26-053559.md) |
| Current portion of debt | $m | [25.2](/filings/0001819516-23-000059.md) | [24.0](/filings/0001819516-25-000012.md) | [22.3](/filings/0001819516-24-000027.md) | [21.2](/filings/0001819516-24-000047.md) | [30.0](/filings/0001819516-24-000066.md) | [31.7](/filings/0001628280-26-016512.md) | [31.7](/filings/0001819516-25-000028.md) | [31.5](/filings/0001819516-25-000044.md) | [30.3](/filings/0001628280-25-049230.md) | [19.0](/filings/0001628280-26-053559.md) | [21.7](/filings/0001628280-26-033583.md) | [21.1](/filings/0001628280-26-053559.md) |
| Shareholders' equity | $m | [145](/filings/0001819516-23-000059.md) | [97.4](/filings/0001819516-25-000012.md) | [0.9](/filings/0001819516-24-000027.md) | [(72.2)](/filings/0001819516-24-000047.md) | [(118)](/filings/0001819516-24-000066.md) | [(202)](/filings/0001628280-26-016512.md) | [(288)](/filings/0001819516-25-000028.md) | [(348)](/filings/0001819516-25-000044.md) | [(375)](/filings/0001628280-25-049230.md) | [(392)](/filings/0001628280-26-053559.md) | [(466)](/filings/0001628280-26-033583.md) | [(560)](/filings/0001628280-26-053559.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(250) d](/filings/0001819516-24-000066.md) | [(3.8) d](/filings/0001628280-26-016512.md) | [(73.8)](/filings/0001819516-25-000028.md) | [(25.2) d](/filings/0001819516-25-000044.md) | [(16.9) d](/filings/0001628280-25-049230.md) | [37.9 d](/filings/0001628280-26-016512.md) | [(47.9)](/filings/0001628280-26-033583.md) | [(62.9) d](/filings/0001628280-26-053559.md) | [(37.1) d](/filings/0001628280-25-049230.md) | [(18.4) d](/filings/0001628280-26-016512.md) | [(99.6)](/filings/0001628280-26-033583.md) | [(91.6) d](/filings/0001628280-26-053559.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001819516-24-000066.md) | [7.9 d](/filings/0001628280-26-016512.md) | [4.0](/filings/0001819516-25-000028.md) | [5.6 d](/filings/0001819516-25-000044.md) | [5.1 d](/filings/0001628280-25-049230.md) | [108 d](/filings/0001628280-26-016512.md) | [14.7](/filings/0001628280-26-033583.md) | [15.8 d](/filings/0001628280-26-053559.md) | [23.3 d](/filings/0001628280-25-049230.md) | [39.9 d](/filings/0001628280-26-016512.md) | [62.4](/filings/0001628280-26-033583.md) | [52.9 d](/filings/0001628280-26-053559.md) |
| Share repurchases | $m | [0.0 d](/filings/0001819516-24-000066.md) | [0.0 d](/filings/0001628280-26-016512.md) | [0.3](/filings/0001819516-25-000028.md) | [0.1 d](/filings/0001819516-25-000044.md) | [0.1 d](/filings/0001628280-25-049230.md) | [(0.0) d](/filings/0001628280-26-016512.md) | [0.1](/filings/0001628280-26-033583.md) | [0.1 d](/filings/0001628280-26-053559.md) | [0.9 d](/filings/0001628280-25-049230.md) | [0.5 d](/filings/0001628280-26-016512.md) | [0.2](/filings/0001628280-26-033583.md) | [0.0 d](/filings/0001628280-26-053559.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [248](/filings/0001819516-23-000023.md) | [25.3](/filings/0001819516-24-000027.md) | [25.6](/filings/0001819516-24-000047.md) | [41.3](/filings/0001819516-24-000066.md) | [698](/filings/0001819516-25-000028.md) | [697](/filings/0001819516-25-000044.md) | [698](/filings/0001628280-25-049230.md) | [34.9](/filings/0001628280-26-033583.md) | [34.9](/filings/0001628280-26-053559.md) | [704](/filings/0001628280-25-049230.md) | [36.1](/filings/0001628280-26-033583.md) | [36.1](/filings/0001628280-26-053559.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,275,841 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053559.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.